A new blood-based signature predicts type 2 diab
Author: Michael
New study shows APOE genetics may explain up to
Milan-based healthtech startup closes $2.
Up to $287 million Series D1 backs CORXEL’s bi
Alterity Therapeutics Ltd.
Life Time Group Holdings, Inc., the U.S.
BioAge Labs, Inc.
Hundred Health founder on why building the ‘de
Pooled MRI and memory data from thousands of adu
L-Nutra to establish manufacturing center in Abu